Medical specialists from Italy tagged as investigators in clinical trials studying Alport Syndrome
Total 4 results
-
Ciro EspositoSeen in:
- Lombardy, Pavia, Fondazione Salvatore Maugeri IRCCS
- Pavia, Fondazione Salvatore Maugeri IRCCS
- Pavia, ICS Maugeri SpA SB
Trials:- NCT04573920 (Principal Investigator)
- NCT04573478 (Principal Investigator)
-
Francesca Chiara ViazziSeen in:
- Genova, Azienda Ospedaliero Universitaria San Martino
- Liguria, Genova, IRCCS Ospedale Policlinico San Martino
Trials:- NCT04573920 (Principal Investigator)
- NCT04573478 (Principal Investigator)
-
Marina VivarelliSeen in:
- Lazio, Rome, Ospedale Pediatrico Bambino Gesù
Trials:- NCT04573920 (Principal Investigator)
-
Matias TrilliniSeen in:
- Lombardy, Pavia, Instituto di Ricerche Farmacologiche Mario Negri, Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Daccó
- Ranica, Istituto Di Ricerche Farmacologiche Mario Negri
Trials:- NCT04573920 (Principal Investigator)
- NCT04573478 (Principal Investigator)
Clinical Trials on Alport Syndrome
-
Genzyme, a Sanofi CompanyCompletedAlport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2France, Germany, Australia, United States, United Kingdom, Canada
-
Novartis PharmaceuticalsCompletedAlport NephropathyUnited States
-
Shanghai Children's HospitalRecruitingAlport Syndrome, X-LinkedChina
-
Genzyme, a Sanofi CompanyCompleted
-
Xinhua Hospital, Shanghai Jiao Tong University...Recruiting
-
University of MinnesotaPeking University First Hospital; University of Toronto; University of Utah; University... and other collaboratorsCompletedAlport SyndromeUnited States
-
Eloxx Pharmaceuticals, Inc.Recruiting
-
Xinhua Hospital, Shanghai Jiao Tong University...Not yet recruiting
-
Mario Negri Institute for Pharmacological ResearchCompletedAlport SyndromeItaly
-
Peking University First HospitalNot yet recruitingMetformin | Alport Syndrome